Human immunodeficiency virus type 1 neutralization is determined by epitope exposure on the gp120 oligomer

Journal of Experimental Medicine

Volumn 182, Issue 1, 1995, Pages 185-196

  Sattentau, Quentin J ^a   Moore, John P ^b  

^a CENTRE D IMMUNOLOGIE DE MARSEILLE LUMINY   (France)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN GP 120; MONOCLONAL ANTIBODY; OLIGOMER;

ANTIBODY RESPONSE; ANTIGEN RECOGNITION; ARTICLE; BINDING AFFINITY; CELL SPECIFICITY; EPITOPE MAPPING; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; MOLECULAR CLONING; PRIORITY JOURNAL; PROTEIN DOMAIN; RECEPTOR BINDING; VIRUS NEUTRALIZATION;

ANTIBODIES, MONOCLONAL; ANTIBODY AFFINITY; ANTIGEN-ANTIBODY REACTIONS; ANTIGENS, CD4; CELL LINE; COMPARATIVE STUDY; EPITOPES; HIV ANTIBODIES; HIV ENVELOPE PROTEIN GP120; HIV-1; HUMAN; NEUTRALIZATION TESTS; PEPTIDE FRAGMENTS; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; VIRION;

EID: 0028999803     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.182.1.185     Document Type: Article

References (66)

1. Sattentau, Q.J., and R.A. Weiss. 1988. The CD4 molecule: physiological ligand and HIV receptor. Cell. 52: 631-633.
2. Moore, J.P., B. Jameson, R.A. Weiss, and Q.J. Sattentau. 1992. The HIV-cell fusion reaction. In Viral Fusion Mechanisms. J. Bentz, editor. CRC Press Inc., Boca Raton, FL. 233-289.
3. Sonigo, P., M. Girard, and D. Dormont. 1990. Design and trials of AIDS vaccines. Immunol. Today. 11: 465-471.
4. Fung, M.S.C., C. Sun, N.-C. Sun, N.T. Chang, and T.W. Chang. 1987. Monoclonal antibodies that neutralise HIV-1 virions and inhibit syncytium formation by infected cells. Biotechnology. 5: 940-947.
5. Goudsmit, J., C.A.B. Boucher, R.H. Meloen, L.G. Epstein, L. Smit, L. van der Hoek, and M. Bakker. 1988. Human antibody response to a strain specific HIV-1 gpl20 epitope associated with cell fusion inhibition. AIDS (Phila.). 2: 157-164.
6. Palker, T.J., M.E. Clark, A.J. Langlois, T.J. Matthews, K.J. Weinhold, R.R. Randall, D.P. Bolognesi, and B.F. Haynes. 1988. Type specific neutralisation of the human immunodeficiency virus with antibodies to env-encoded synthetic peptides. Proc. Natl Acad. Sci. USA. 85: 1932-1936.
7. Rusche, J.R., K. Javaherian, M. McDanal, J. Petro, D.L. Lynn, R. Grimaila, A. Langlois, R.C. Gallo, L.O. Arthur, P.J. Fischinger, et al. 1988. Antibodies that inhibit fusion of HIV-1-infected cells bind a 24 amino acid sequence of the viral envelope gpl20. Proc. Natl. Acad. Sci. USA. 85: 7023-7027.
8. Skinner, M.A., R. Ting, A.J. Langlois, K.J. Weinhold, H.K. Lyerly, K. Javaherian, and T.J. Matthews. 1988. Characteristics of a neutralising monoclonal antibody to the HIV envelope glycoprotein. AIDS Res. Hum. Retroviruses. 4: 187-197.
9. Kinney-Thomas, E., J.N. Weber, J. McClure, P.R. Clapham, M. C. Singhal, M.K. Shriver, and R.A. Weiss. 1988. Neutralising monoclonal antibodies to the AIDS virus. AIDS (Phila.). 2: 25-29.
10. Meloen, R.H., R.M. Liskamp, and J. Goudsmit. 1989. Specificity and function of the individual amino acids of an important determinant of human immunodeficiency virus type 1 that induces neutralising activity. J. Gen. Virol. 70: 1505-1512.
11. Profy, A.T., P.A. Salinas, L.I. Eckler, N.M. Dunlop, P.L. Nara, and S. Putney. 1990. Epitopes recognised by the neutralising antibodies of an HIV-infected individual. J. Immunol. 144: 4641-4648.
12. Liou, R.-S., E.M. Rosen, M.S.C. Fung, W.N.C. Sun, C. Sun, W. Gordon, N.T. Chang, and T.W. Chang. 1989. A chimeric mouse-human antibody that retains specificity for HIV gpl20 and mediates the lysis of HIV-infected cells. J. Immunol. 143: 3967-3975.
13. Durda, P.J., L. Bacheler, P. Clapham, A.M. Jenoski, B. Leece, T.J. Matthews, A. McKnight, R. Pomerantz, M. Rayner, and K. Weinhold. 1990. HIV-1 neutralizing monoclonal antibodies induced by a synthetic peptide. AIDS Res. Hum. Retroviruses. 6: 1115-1123.
14. Gorny, M.K., J.-Y. Xu, V. Gianakakos, S. Karwowska, C. Williams, H.W. Sheppard, C.V. Hanson, and S. Zolla-Pazner. 1991. Production of site-selected neutralising human monoclonal antibodies against the third variable domain of the HIV-1 envelope glycoprotein. Proc. Natl. Acad. Sci. USA. 88: 3238-3242.
15. Laman, J.D., M.M. Schellekens, Y.H. Abacioglu, G.K. Lewis, M. Tersmette, R. A.M. Fouchier, J.P.M. Langedijk, E. Classen, and W.J.A. Boersma. 1992. Variant-specific monoclonal and group-specific polyclonal human immunodeficiency virus type-1 neutralising antibodies raised with synthetic peptides from the gpl20 third variable domain. J. Virol. 66: 1823-1831.
16. McKeating, J.A., J. Cordell, C.J. Dean, and P. Balfe. 1992. Synergistic interaction between ligands binding to the CD4 binding site and V3 domain of human immunodeficiency virus type 1 gpl20. Virology. 191: 732-742.
17. Ho., D.D., M.S.C. Fung, Y. Cao, X.L. Li., C. Sun, T.W. Chang, and N-C. Sun. 1991. Another discontinuous epitope on glycoprotein gpl20 that is important in human immunodeficiency virus type 1 neutralisation is identified by a monoclonal antibody. Proc. Natl. Acad. Sci. USA. 88: 8949-8952.
18. Fung, M.S.C., C.R.Y. Sun, W.L. Gordon, R.-S. Liou, T.W. Chang, W.N.C. Sun, E.S. Daar, and D.D. Ho. 1992. Identification and characterisation of a neutralization site within the second variable region of human immunodeficiency virus type 1 gpl20. J. Virol. 66: 848-856.
19. Moore, J.P., Q.J. Sattentau, H. Yoshiyama, M. Thali, M. Charles, N. Sullivan, S.-W. Poon, M.S. Fung, F. Traincard, M. Pinkus, et al. 1993. Probing the structure of the V2 domain of the human immunodeficiency virus type 1 surface glycoprotein gpl20 with a panel of eight monoclonal antibodies: the human immune response to the VI and V2 domains. J. Virol. 67: 6136-6151.
20. McKeating, J.A., C. Shotton, J. Cordell, S. Graham, P. Balfe, N. Sulliven, M. Charles, M. Page, A. Bolmstedt, S. Oloffson, et al. 1993. Characterisation of neutralising monoclonal antibodies to linear and conformational dependent epitopes within the first and second variable domains of human immunodeficiency virus type 1 gpl20. J. Virol. 67: 4932-4944.
21. Sun, N.C., D.D. Ho, C.R.Y. Sun, R.-S. Liou, W. Gordon, M. S.C. Fung, X.-L. Li, R.C. Ting, T.-H. Lee, N.T. Chang, and T.W. Chang. 1989. Generation and characterization of monoclonal antibodies to the putative CD4-binding domain of HIV-1 gpl20. J. Virol. 63: 3579-3585.
22. McKeating, J.A., J.P. Moore, M. Ferguson, H.S. Marsden, S. Graham, J.W. Almond, D.J. Evans, and R.A. Weiss. 1992. Monoclonal antibodies to the C4 region of human immunodeficiency virus type 1 gpl20: use in topological analysis of a CD4 binding site. AIDS Res. Hum. Retroviruses. 8: 451-459.
23. Moore, J.P., M. Thali, B.A. Jameson, F. Vignaux, G.K. Lewis, S.-W. Poon, M. Charles, M.S. Fung, B. Sun, P.J. Durda, et al. 1993. Immunochemical analysis of the gpl20 surface glycoprotein of human immunodeficiency virus type 1: probing the structure of the C4 and V4 domains and the interaction of the C4 domain with the V3 loop. J. Virol. 67: 4785-4796.
24. Ho, D.D., J.A. McKeating, X.L. Li, T. Moudgil, E.S. Daar, N. -C. Sun, and J.E. Robinson. 1991. Conformational epitope on gpl20 important in CD4 binding and human immunodeficiency virus type 1 neutralization identified by a human monoclonal antibody. J. Virol. 65: 489-493.
25. Thali, M., U. Olshevsky, C. Furman, D. Gabudza, M. Posner, and J. Sodroski. 1991. Characterisation of a discontinuous human immunodeficiency virus type 1 epitope recognised by a broadly reactive neutralizing human monoclonal antibody. J. Virol. 65: 6188-6193.
26. Thali, M., C. Furman, D.D. Ho, J. Robinson, S. Tilley, A. Pinter, and J. Sodroski. 1992. Discontinuous, conserved neutralization epitopes overlapping the CD4-binding region of human immunodeficiency virus type-1 gpl20 envelope glycoprotein. J. Virol. 66: 5635-5641.
27. Thali, M., J.P. Moore, C. Furman, M.A. Charles, D.D. Ho, J. Robinson, and J. Sodroski. 1993. Characterisation of conserved human immunodeficiency virus type 1 gpl20 neutralization epitopes exposed upon gpl20-CD4 binding. J. Virol. 67: 3978-3988.
28. Moore, J.P., Q.J. Sattentau, R. Wyatt, and J. Sodroski. 1994. Mapping the topology of the human immunodeficiency virus surface glycoprotein gpl20 with a panel of monoclonal antibodies. J. Virol. 68: 469-484.
29. Javaherian, K., A.J. Langlois, G.J. LaRosa, A.T. Profy, D.P. Bolognesi, W.C. Herlihy, S.D. Putney, and T.J. Matthews. 1990. Broadly neutralizing antibodies elicited by the hypervariable neutralizing determinant of HIV-1. Science (Wash. DC). 250: 1590-1593.
30. Ohno, T., M. Terada, Y. Yoneda, K.W. Shea, R.F. Chambers, D.M. Stroka, M. Nakamura, and D.W. Kulfe. 1991. A broadly neutralizing monoclonal antibody that recognises the V3 region of human immunodeficiency virus type 1 glycoprotein gpl20. Proc. Natl. Acad. Sci. USA. 88: 10726-10729.
31. Steimer, K.S., C.J. Scandella, P.V. Skiles, and N.L. Haigwood. 1991. Neutralization of divergent HIV-1 isolates by conformation-dependent human antibodies to gpl20. Science (Wish. DC). 254: 105-108.
32. Gomy, M.K., A.J. Conley, S. Karwowska, A. Buchbinder, J.-Y. Xu, E.A. Emini, S. Koenig, and S. Zolla-Pazner. 1992. Neutralization of diverse human immunodeficiency virus type 1 variants by an anti-V3 human monoclonal antibody. J. Virol. 66: 7538-7542.
33. Sullivan, N., M. Thali, C. Furman, D.D. Ho, and J. Sodroski. 1993. Effect of amino acid changes in the V1/V2 region of the human immunodeficiency virus type 1 gpl20 glycoprotein on subunit association, syncytium formation and recognition by a neutralizing antibody. J. Virol. 67: 3674-3679.
34. Lasky, L.A., G.M. Nakamura, D.H. Smith, C. Fennie, C. Shimasaki, E. Patzer, P. Berman, T. Gregory, and D.J. Capon. 1987. Delineation of a region of the human immunodeficiency virus type 1 gpl20 glycoprotein critical for interaction with the CD4 receptor. Cell. 50: 975-985.
35. Cordonnier, A., Y. Riviere, L. Montagnier, and M. Emerman. 1989. Effects of mutations in hyperconserved regions of the extracellular glycoprotein of human immunodeficiency virus type 1 on receptor binding. J. Virol. 63: 4464-4468.
36. Olshevsky, U., E. Helseth, C. Furman, J. Li, W. Haseltine, and J. Sodroski. 1990. Identification of individual human immunodeficiency virus type 1 gpl20 amino acids important for CD4 receptor binding. J. Virol. 64: 5701-5707.
37. Robinson, J., D. Holton, S. Pacheco-Morell, J. Liu, and H. McMurdo. 1990. Identification of conserved and variant epitopes of HIV-1 gpl20 by human monoclonal antibodies produced by EBV-transformed cell lines. AIDS Res. Hum. Retroviruses. 6: 567-580.
38. Posner, M., T. Hideshima, T. Cannon, M. Mukherjee, K. Mayer, and R. Byrn. 1991. An IgG human monoclonal antibody which reacts with HIV-1 gpl20, inhibits virus binding to cells, and neutralises infection. J. Immunol. 146: 4325-4332.
39. Tilley, S.A., W.J. Honnen, M. Racho, M, Hilgartner, and A. Pinter. 1991. A human monoclonal antibody against the CD4 binding site of HIV-1 gpl20 exhibits potent, broadly neutralising activity. Res. Virol. 142: 247-259.
40. Karwowska, S., M.K. Gorny, A. Buchbinder, V. Giankakos, C. Williams, T. Fuerst, and S. Zolla-Pazner. 1992. Production of human monoclonal antibodies specific for conformational and linear non-V3 epitopes of gpl20. AIDS Res. Hum. Retroviruses. 8: 1099-1106.
41. Robinson, J.E., H. Yoshiyama, D. Holton, S. Elliott, and D.D. Ho. 1992. Distinct antigenic sites on HIV gpl20 identified by a panel of human monoclonal antibodies. J. Cell. Biochem. 449(Suppl. 16E): 71. (Abstr.)
42. Schawaller, M., C.E. Smith, J.J. Skehel, and D.C. Wiley. 1989. Studies with cross-linking reagents on the oligomeric structure of the env glycoprotein of HIV. Virology. 172: 367-369.
43. Earl, P.L., R.W. Dorns, and B. Moss. 1990. Oligomeric structure of the human immunodeficiency virus type-1 envelope glycoprotein. Proc. Natl. Acad. Sci. USA. 87: 648-652.
44. Weiss, C.D., J.A. Levy, and J.M. White. 1990. Oligomeric organisation of gpl20 on infectious human immunodeficiency virus type 1 particles. J. Virol. 64: 5674-5677.
45. Dorns, R.W., P.L. Earl, S. Chakrabarti, and B. Moss. 1990. Human immunodeficiency viruses types 1 and 2 and simian immunodeficiency virus env proteins possess a functionally conserved assembly domain. J. Virol. 64: 3537-3540.
46. Gelderblom, H.R., M. Ozel, E.H.S. Hausmann, T. Winkel, G. Pauli, and M.A. Koch. 1988. Fine structure of human immunodeficiency virus (HIV), immunolocalisation of structural proteins and virus-cell relation. Micron Microsc. Acta. 19: 41-60.
47. Dalgleish, A.G., P.C.L. Beverley, P.R. Clapham, D.H. Crawford, M.F. Greaves, and R.A. Weiss. 1984. The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus. Nature (Land.). 312: 763-766.
48. Moore, J.P. 1990. Simple methods for monitoring HIV-1 and HIV-2 gpl20 binding to sCD4 by ELISA: HIV-2 has a 25-fold lower affinity than HIV-1 for sCD4. AIDS (Phila.). 3: 297-305.
49. Weiss, S.H., J.J. Goedert, S. Gartner, M. Popovic, D. Waters, P. Markham, F. di M. Veronese, M.H. Gail, W.E. Barcley, J. Gibbons, F.A. Gill, M. Leuther, G.M. Shaw, R.C. Gallo, and W.A. Blattner. 1988. Risk of human immunodeficiency virus (HIV-1) infection among laboratory workers. Science (Wash. DC). 239: 68-71.
50. Lasky, L.A., J.E. Groopman, C.W. Fennie, P.M. Benz, D.J. Capon, D.J. Dowbenko, G.R. Nakamura, W.M. Nunes, M.E. Renz, and P.W. Berman. 1986. Neutralization of the AIDS retrovirus by antibodies to a recombinant envelope glycoprotein. Science (Wish. DC). 233: 209-212.
51. Fisher, A.G., E. Collati, L. Ratner, R.C. Gallo, and F. Wong-Staal. 1985. A molecular clone of HTLV-III with biological activity. Nature (Lond.). 316: 262-265.
52. Mason, D.W., and A.F. Williams. 1988. Kinetics of antibody reactions and the analysis of cell surface antigens. In Handbook of Experimental Immunology 1: Immunochemistry. D.M. Weir, editor. Blackwell Scientific Publications, Oxford. 38.1-17.
53. Clavel, F., and P. Chameau. 1994. Fusion from without directed by human immunodeficiency virus particles. J. Virol. 68: 1179-1185.
54. Weiss, R.A., P.R. Clapham, J.N. Weber, A.G. Dalgleish, L.A. Lasky, and P.W. Berman. 1986. Variable and conserved neutralisation antigens of human immunodeficiency virus. Nature (Lond.). 324: 572-575.
55. Sattentau, Q.J., and J.P. Moore. 1991. Conformational changes induced in the human immunodeficiency virus envelope glycoprotein by soluble CD4 binding. J. Exp. Med. 174: 407-415.
56. Sattentau, Q.J., J.P. Moore, F. Vignaux, F. Traincard, and P. Poignard. 1993. Conformational changes induced in the envelope glycoproteins of the human and simian immunodeficiency viruses by soluble receptor binding. J. Virol. 67: 7383-7393.
57. Ikuta, K., C. Morita, S. Miyake, T. Ito, M. Okabayashi, K. Sano, M. Nakai, K. Hirai, and S. Kato. 1989. Expression of human immunodeficiency virus type-1 (HIV-1) gag antigens on the surface of a cell line persistently infected with HIV-1 that highly expresses HIV-1 antigens. Virology. 170: 408-418.
58. Sattentau, Q.J., S. Zolla-Pazner, and P. Poignard. 1995. Epitope expression on oligomeric functional HIV-1 gp41. Virology. 206: 713-717.
59. Levy, J.A. 1993. Pathogenesis of human immunodeficiency virus infection. Microbiol. Rev. 57: 183-289.
60. Moore, J.P., and D. Ho. 1993. Antibodies to discontinuous or conformationally sensitive epitopes on the gpl20 glycoprotein of human immunodeficiency virus type 1 are highly prevalent in sera of infected humans. J. Virol. 67: 863-875.
61. Earl, P.L., C.C. Broder, D. Long, S.A. Lee, J. Peterson, S. Chakrabarti, R.W. Dorns, and B. Moss. 1994. Native oligomeric human immunodeficiency virus type 1 envelope glycoprotein elicits diverse monoclonal antibody reactivities. J. Virol. 68: 3015-3026.
62. Bou-Habib, D.C., G. Rodriquez, T. Oravecz, P.W. Berman, P. Lusso, and M. Norcross. 1994. Cryptic nature of envelope V3 region epitope protects primary monocytotropic human immunodeficiency virus type 1 from antibody neutralization. J. Virol. 68: 6006-6013.
63. Moore, J.P., Y. Cao, L. Quing, Q.J. Sattentau, J. Pyati, R. Koduri, J. Robinson, C.F. Barbas, III, D.R. Burton, and D.D. Ho. 1995. Primary isolates of human immunodeficiency virus type 1 are relatively resistant to neutralization by monoclonal antibodies to gpl20 and their neutralization is not predicted by studies with monomeric gpl20. J. Virol 69: 101-109.
64. Moore, J.P., A. Trkola, B. Korber, L.J. Boots, J.A. Kessler II, F.E. McKutchan, J. Mascola, D.D. Ho, J. Robinson, and A.J. Conley. 1995. A human monoclonal antibody to a complex epitope in the V3 region of gpl20 of human immunodeficiency virus type 1 has broad reactivity within and outside clade B. J. Virol. 69: 122-130.
65. VanCott, T.C., F.R. Bethke, V.R. Polonis, M.K. Gorny, S. Zolla-Pazner, R.R. Redfield, and D. Birx. 1994. Dissociation rate of antibody-gpl20 binding interactions is predictive of V3-mediated neutralization of HIV-1. J. Immunol 153: 449-459.
66. Stern, T.L., M.S. Reitz, Jr., and M. Robert-Guroff. 1995. Spontaneous reversion of human immunodeficiency virus type 1 neutralization-resistant variant HXB2thr582: in vitro selection against cytopathicity highlights gpl20-gp41 interactive regions. J. Virol. 69: 1860-1867.